California State Teachers Retirement System trimmed its holdings in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 8.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,044,640 shares of the company’s stock after selling 102,595 shares during the quarter. California State Teachers Retirement System owned 0.18% of Express Scripts worth $66,147,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Park National Corp OH boosted its stake in shares of Express Scripts by 0.3% in the 2nd quarter. Park National Corp OH now owns 3,575 shares of the company’s stock valued at $228,000 after purchasing an additional 11 shares during the last quarter. Parkside Financial Bank & Trust boosted its stake in shares of Express Scripts by 0.3% in the 2nd quarter. Parkside Financial Bank & Trust now owns 8,634 shares of the company’s stock valued at $551,000 after purchasing an additional 23 shares during the last quarter. CAPROCK Group Inc. boosted its stake in shares of Express Scripts by 0.9% in the 2nd quarter. CAPROCK Group Inc. now owns 3,675 shares of the company’s stock valued at $235,000 after purchasing an additional 33 shares during the last quarter. Sandy Spring Bank boosted its stake in shares of Express Scripts by 0.6% in the 2nd quarter. Sandy Spring Bank now owns 6,464 shares of the company’s stock valued at $413,000 after purchasing an additional 37 shares during the last quarter. Finally, Honkamp Krueger Financial Services Inc. boosted its stake in shares of Express Scripts by 0.8% in the 2nd quarter. Honkamp Krueger Financial Services Inc. now owns 4,762 shares of the company’s stock valued at $304,000 after purchasing an additional 38 shares during the last quarter. 88.44% of the stock is currently owned by hedge funds and other institutional investors.

Express Scripts Holding Company (ESRX) opened at $68.57 on Thursday. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.61 and a current ratio of 0.73. Express Scripts Holding Company has a 12 month low of $55.80 and a 12 month high of $73.42. The stock has a market cap of $38,830.00, a price-to-earnings ratio of 10.00, a P/E/G ratio of 1.01 and a beta of 0.88.

Express Scripts (NASDAQ:ESRX) last released its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.90. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The firm had revenue of $24.68 billion for the quarter, compared to the consensus estimate of $25.68 billion. During the same quarter in the prior year, the company posted $1.74 earnings per share. The business’s revenue was down 2.9% on a year-over-year basis. analysts predict that Express Scripts Holding Company will post 7.01 EPS for the current year.

In other Express Scripts news, CEO Timothy C. Wentworth acquired 8,000 shares of the stock in a transaction on Tuesday, October 31st. The shares were purchased at an average price of $61.13 per share, for a total transaction of $489,040.00. Following the completion of the acquisition, the chief executive officer now owns 98,628 shares in the company, valued at approximately $6,029,129.64. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, VP Phyllis S. Anderson sold 643 shares of the company’s stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $62.37, for a total transaction of $40,103.91. The disclosure for this sale can be found here. Corporate insiders own 0.68% of the company’s stock.

A number of equities research analysts have recently commented on ESRX shares. ValuEngine lowered shares of Express Scripts from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Robert W. Baird reaffirmed a “hold” rating and issued a $56.00 price objective on shares of Express Scripts in a research note on Friday, September 1st. Jefferies Group set a $72.00 target price on shares of Express Scripts and gave the stock a “buy” rating in a research note on Tuesday, August 29th. Raymond James Financial reissued an “underperform” rating on shares of Express Scripts in a research note on Monday, October 9th. Finally, Zacks Investment Research lowered shares of Express Scripts from a “buy” rating to a “sell” rating in a research note on Tuesday, October 24th. Five research analysts have rated the stock with a sell rating, eleven have given a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $70.67.

TRADEMARK VIOLATION WARNING: “California State Teachers Retirement System Trims Holdings in Express Scripts Holding Company (ESRX)” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this story can be read at https://www.thecerbatgem.com/2017/12/14/california-state-teachers-retirement-system-trims-holdings-in-express-scripts-holding-company-esrx.html.

Express Scripts Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Stock Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related stocks with our FREE daily email newsletter.